Former Smokers Share Their Cessation Strategies

The review analyzed data on the risks of influenza infection and severe course in tobacco smokers compared with non-smokers. The incidence of influenza in the Russian Federation in 2018 amounted to 26.33 per 100 000 people, and was 24% lower than the incidence in 2017 (34.86 per 100 000) due to the fact that in recent years the coverage of the population with preventive vaccinations has been significantly increased against the flu. Meta-analyzes shows that current smokers are more likely to get the flu than non-smokers. It is noted that smoking may increase the risk of hospitalization in smokers (OR 1.32–2.18 in various meta-analyzes) and former smokers after infection with the influenza virus. Tobacco has been found to increase the risk of death from influenza among older people. At the same time, there is a study of risk factors for severe outcomes in patients hospitalized with the 2009 H1N1 pandemic flu, in which smoking was not a risk factor for severe outcomes. During the influenza epidemic, smokers and former smokers should be given the flu shot and be informed of the risk of hospitalization, and they are also strongly advised to stop smoking.

Download Full-text

Cancer of the Lung, Larynx, and Pleura

10.1093/oso/9780190676827.003.0014 ◽

2018 ◽

Author(s):

Jyoti Malhotra ◽

Paolo Boffetta ◽

Lorelei Mucci

Keyword(s):

Lung Cancer ◽

Secondhand Smoke ◽

Lung Cancer Risk ◽

Occupational Exposures ◽

Men And Women ◽

Established Risk Factor ◽

Former Smokers ◽

Never Smokers ◽

Exposure To Secondhand Smoke ◽

Cancer Of The Lung

Lung cancer is the most commonly diagnosed cancer among men in most countries, and is the primary cause of cancer death in men and women. Its epidemic increase in incidence began in the first half of the twentieth century, paralleling the uptake of cigarette smoking that occurred 20 years before. A series of landmark studies beginning in 1950 established tobacco as the primary cause of lung cancer. Current smokers have a 10- to 20-fold higher lung cancer risk compared to never smokers. Important for prevention, former smokers substantially reduce this excess risk 5 years after smoking cessation. Exposure to secondhand smoke, a well-established risk factor for lung cancer, has a 20%–25% higher risk for those exposed. There are several occupational exposures associated with lung cancer, including asbestos. Despite the success in defining lung cancer’s etiology, this highly preventable disease remains among the most common and most lethal cancers globally.

Download Full-text

Electronic Monitoring of Long-Term use of Nicotine Nasal Spray in Former Smokers

Journal of General Internal Medicine ◽

10.1046/j.1525-1497.2000.15200-3x./ ◽

2000 ◽

Vol 15 (s2) ◽

pp. 1-1

Author(s):

M-P Schneider ◽

G Van Melle ◽

J-P Zellweger ◽

C Uldry ◽

M Burnier

Keyword(s):

Nasal Spray ◽

Electronic Monitoring ◽

Former Smokers

Download Full-text

Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial

Advances in Therapy ◽

10.1007/s12325-021-01855-y ◽

2021 ◽

Author(s):

Leif H. Bjermer ◽

Isabelle H. Boucot ◽

Claus F. Vogelmeier ◽

François Maltais ◽

Paul W. Jones ◽

...

Keyword(s):

Efficacy And Safety ◽

Former Smokers

Download Full-text

AB0689 THE IMPORTANCE OF THE SUN. VITAMIN D AND SPONDYLOARTHRITIS: OUR EXPERIENCE IN A THIRD LEVEL HOSPITAL.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2020-eular.4191 ◽

2020 ◽

Vol 79 (Suppl 1) ◽

pp. 1640.2-1640

Author(s):

I. González Fernández ◽

C. Álvarez Castro ◽

C. Moriano ◽

A. López Robles ◽

X. E. Larco Rojas ◽

...

Keyword(s):

New York ◽

Vitamin D ◽

Disease Activity ◽

Intestinal Inflammation ◽

Reference Value ◽

Hypovitaminosis D ◽

Lower Severity ◽

Inflammatory Bowel ◽

Former Smokers ◽

Low Levels

Background:Vitamin D plays an important role in the pathogenesis of autoimmune diseases, so that it has been shown that an adequate level is associated with a lower risk of developing this group of entities as well as a lower severity of them. Specifically, in spondyloarthritis (SpA) the deficiency has been associated with greater aggressiveness and greater radiological progression.Objectives:Assess levels of vitamin D in patients diagnosed with SpA in the León University Assistance Complex and study its possible relationship with different clinical-epidemiological variables.Methods:Prospective observational study between January 1, 2019 and December 31, 2019 with consecutive sampling of patients diagnosed with SpA (New York criteria, ASAS) in our hospital between 1973 and 2018. It was taken as a cut-off point for vitamin normality D those values ≥ 30 ng / ml. The disease activity was assessed based on BASDAI and CRP level (taking as a cut-off point 5 mg/l, reference value of our hospital and ruling out elevation due to intercurrent processes) in the last consultation. Positive values above 130 mlg/dL were considered for the orosomucoid and for calprotectin as undetermined values between 50-100 mg/kg feces and suspected IBD greater than 100 mg/kg feces. An attempt was made to link the value of vitamin D with disease activity, tobacco, the development of uveitis and the presence of subclinical intestinal inflammation.Results:132 patients were included, of which 60.6% were men with a mean age of 49.35 ± 12.95 years. 84.8% were B27 positive. 88.6% met New York criteria. 35.6% suffered uveitis at some time during their evolution. As for tobacco, 68.2% were non-smokers, 12.9% were former smokers and 18.9% were active smokers. 6.8% of the sample presented positivity for the orosomucoid and 37.8% alterations in calprotectin (of which 24.2% were undetermined and 13.6% suspected of inflammatory bowel disease). Only 25% of patients had elevated CRP levels and 11.4% of patients had BASDAI> 4. 50.8% of our sample had optimal levels of Vitamin D while 49.2% were at low values.A statistically significant association was observed between hypovitaminosis D and elevated CRP levels (p 0.038). In our sample we found no statistical association with uveitis or with markers of subclinical inflammatory activity.Conclusion:-Almost half of the patients in our sample have hypovitaminosis D which is probably attributable to the meteorological characteristics of León region.-Low levels of vitamin D are statistically significantly related to higher levels of CRP and, therefore, with greater disease activity.-No significant relationship was found with uveitis or with a higher risk of subclinical intestinal inflammation in our simple.References:[1]Castro Domínguez F, Salman Monte TC, Blanch Rubió J. Vitamin D in rheumatic diseases.Rev Osteoporos Metab Miner. 2017; 9 (1) supplement: 31-39.Disclosure of Interests:None declared

Download Full-text

Current or former smokers: Who wants to be screened?

Annals of Oncology ◽

10.1093/annonc/mdw387.18 ◽

2016 ◽

Vol 27 ◽

pp. vi478

Author(s):

S. Couraud ◽

L. Greillier ◽

X. Pivot ◽

L. Guibaudet ◽

J.-Y. Blay ◽

...

Keyword(s):

Former Smokers

Download Full-text

Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care

BMC Cancer ◽

10.1186/s12885-021-08439-7 ◽

2021 ◽

Vol 21 (1) ◽

Author(s):

Sarah F. Christensen ◽

Robyn M. Scherber ◽

Gina L. Mazza ◽

Amylou C. Dueck ◽

Nana Brochmann ◽

...

Keyword(s):

Quality Of Life ◽

Tobacco Use ◽

Myeloproliferative Neoplasms ◽

Myeloproliferative Neoplasm ◽

Symptom Burden ◽

Symptom Assessment ◽

Cross Sectional ◽

Former Smokers ◽

Never Smokers

Abstract Background Patients with Philadelphia-negative Myeloproliferative Neoplasms (MPN) suffer from numerous symptoms and decreased quality of life. Smoking is associated with an increased symptom burden in several malignancies. The aim of this study was to analyze the association between smoking and MPN-related symptom burden and explore MPN patients’ opinions on smoking. Methods A total of 435 patients with MPN participated in a cross-sectional internet-based survey developed by the Mayo Clinic and the Myeloproliferative Neoplasm Quality of Life Group. Patients reported their demographics, disease characteristics, tobacco use, and opinions on tobacco use. In addition, MPN-related symptoms were reported via the validated 10-item version of the Myeloproliferative Neoplasms Symptom Assessment Form. Results Current/former smokers reported worse fatigue (mean severity 5.6 vs. 5.0, p = 0.02) and inactivity (mean severity 4.0 vs. 3.4, p = 0.03) than never smokers. Moreover, current/former smokers more frequently experienced early satiety (68.5% vs. 58.3%, p = 0.03), inactivity (79.9% vs. 71.1%, p = 0.04), and concentration difficulties (82.1% vs. 73.1%, p = 0.04). Although not significant, a higher total symptom burden was observed for current/former smokers (mean 30.4 vs. 27.0, p = 0.07). Accordingly, overall quality of life was significantly better among never smokers than current/former smokers (mean 3.5 vs. 3.9, p = 0.03). Only 43.2% of the current/former smokers reported having discussed tobacco use with their physician, and 17.5% did not believe smoking increased the risk of thrombosis. Conclusion The current study suggests that smoking may be associated with increased prevalence and severity of MPN symptoms and underscores the need to enhance patient education and address tobacco use in the care of MPN patients.

Download Full-text